Corrigendum: TNF-α in Uveitis: From Bench to Clinic

Front Pharmacol. 2022 Feb 25:13:817235. doi: 10.3389/fphar.2022.817235. eCollection 2022.

Authors

Qi Jiang¹, Zhaohuai Li¹, Tianyu Tao¹, Runping Duan¹, Xianggui Wang^{2

3}, Wenru Su¹

Affiliations

¹ State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.
² Eye Center of Xiangya Hospital, Central South University, Changsha, China.
³ Hunan Key Laboratory of Ophthalmology, Changsha, China.

Abstract

[This corrects the article DOI: 10.3389/fphar.2021.740057.].

Keywords: TNF-α; adalimumab; anti-TNF-α agents; certolizumab pegol; experimental autoimmune uveitis (EAU); golimumab; infliximab; uveitis.

Copyright © 2022 Jiang, Li, Tao, Duan, Wang and Su.

Publication types

Published Erratum